Shareholder Letter
Oslo, September 5, 2022 – Observe Medical ASA (OSE: OBSRV) ("Observe Medical" or the "Company"), a Nordic-based medtech company focused on developing and commercializing proprietary and innovative medtech products to the global market through organic growth and targeted M&A, today publishes a shareholder letter (in Norwegian). The letter to our shareholders is enclosed to this release. For further information, please contact: Rune Nystad, CEO Observe MedicalMobile: +47 916 24 683E-mail: rune.nystad@observemedical.com About Observe Medical Observe Medical is a Nordic